P95 successfully exhibited at the Vaccine World Asia Congress 2024, held on 6-7 November in Bangkok, Thailand. The Congress provided a valuable platform for sharing our capabilities and exploring potential collaborators for vaccine development in Asia and globally. Our participation underscored our commitment to making a difference in global health, fostering partnerships that can drive advancements in the field.

We are experts in vaccine development in Asia and globally

At P95, our ability to adapt and operate seamlessly across diverse regions, including Africa, Latin America, and Southeast Asia, is one of our core strengths. With a presence in these key regions, we leverage local staff and deep regional knowledge to address the unique challenges and opportunities these regions present.

Building partnerships in Asia and globally

At P95, we build partnerships and collaborate with local communities, healthcare institutions, government bodies, NGOs, non-profits, and international research entities to maximize resource efficiency and share best practices. The Vaccine World Asia Congress 2024 was an excellent opportunity to explore potential collaborations in the Southeast Asia region. We connected with various stakeholders, including pharmaceutical companies, research organizations and public health agencies. This enabled us to discuss how we can work together to drive advancements in the field of vaccine development.

Learn more about our global solutions here.

Meet P95 in one of our next events

Every month, P95 participates and exhibits at leading vaccine and infectious disease events. You can check our full event schedule here. Our team of experts is looking forward to talking to you. To those who have visited us during Vaccine World Asia Congress 2024, we are excited to start our collaboration. Stay tuned for updates on our upcoming events and initiatives.

Get in touch with us

Connect with us on our official LinkedIn page or send us a proposal request directly.